Goleta breast implant maker Sientra announced a huge boost in net sales for its first quarter and an infusion of $108 million in cash with the completion of a follow-on equity offering. Net sales reached $14.7 million, nearly double what they were in the first quarter of 2017, with increases in its newer Biocorneum and…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
